A New Model of Celiac Disease: THE GLUTEN TREE, Gluten-free Diet NOT for Celiac Disease Only

1888PressRelease - Press release announcing a new model of celiac disease symbolized as The Gluten Tree published on www.CeliacDiseaseExposed.com. A new perspective follows from observing that gluten's (hidden) effect involves the whole body from the beginning. Celiac disease is considered as only part of a larger gluten-triggered process. The Gluten Tree charts the proven gluten connections in a visual perspective.

An outsider's look inside celiac disease leads to a new model symbolized as The Gluten Tree published by Cotter-Lyons Publications on http://www.CeliacDiseaseExposed.com. The Gluten Tree is founded on existing peer-reviewed research but with a unique key twist, by Nancy J. Lyons, Ph.D. (physical chemistry) for the general audience.

A gluten-free diet is fundamentally one without wheat, rye or barley. Celiac disease is a gluten-triggered condition of the small intestine--by definition. On August 2, 2013, the FDA announced the first gluten-free food labeling standard. As the media outlets reported this long-awaited guideline, the public was also informed that the gluten-free diet has no proven benefit beyond treating celiac disease. Science suggests otherwise.

The scope of gluten's effect is unbounded but largely hidden and celiac disease represents only one part of the anomaly. The gluten-free diet has resolved cases of multiple ailments such as schizophrenia and Advanced Autoimmune Liver Disease. A gluten-free diet on estimation can prevent up to 40% of ataxia cases unknown in origin: Ataxia is a balance and gait impairment stemming from the cerebellum part of the brain. A gluten-free diet has been an effective treatment for a blistering skin condition called dermatitis herpetiformis. The gluten-free diet has resolved cases of childhood alopecia areata, a balding condition.

The Gluten Tree charts the proven gluten connections in a simple yet powerful visual perspective. The focus here is gluten. Gluten triggers the production of an antibody that is circulated via the bloodstream in some people. While the occurrence this "celiac-specific" antibody is not new, it is hypothesized here as the link between gluten-triggered illness within and outside of the small intestine. A blood test that measures this antibody has been available for over 17 years as a screening tool for celiac disease. Moreover, this test could be the most accurate predictor of adults likely to benefit from the gluten-free diet--with or without diagnosed celiac disease. Routine accessibility to this blood test from medical providers could provide the foresight to prevent gluten-related disease and eliminate the many-year journey to subsequent detrimental diagnoses.

Cotter-Lyons Publications is an independent book publisher dedicated exclusively to original work on the subject of celiac disease for the general reader. Cotter-Lyons Publications is a member of the Independent Book Publishers Association.

For more information, see A New Model of Celiac Disease: The Gluten Tree at www.CeliacDiseaseExposed.com/The Gluten Tree. Cotter-Lyons Publications is a member of the Independent Book Publishers Association.

http://www.celiacdiseaseexposed.com/gluten-tree.html

Greengold further announces the issuance of its "Permit to Import Plants and Plants Products" issued by the Usda-Aphis-Ppq Agency that granted the Company a five (5) year expiration permit of August 16, 2018.